MicroRNA‑429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3
Open Access
- 3 February 2021
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 21 (4) , 1
Abstract
Colorectal cancer (CRC) is one of the most common solid tumors worldwide and has an extremely poor prognosis. MicroRNA‑429 (miR‑429) has been reported to participate in the progression of CRC. However, the pathological mechanisms require further investigation. The aim of the present study was to investigate the association between miR‑429 and high mobility group box 3 (HMGB3) in CRC and the associated mechanism. The mRNA expression levels of miR‑429 and HMGB3 in 65 paired CRC and adjacent tissues were examined by reverse transcription‑quantitative PCR. Furthermore, a dual‑luciferase reporter assay was performed to identify the association between miR‑429 and HMGB3. Finally, the effects of miR‑429 and HMGB3 on the proliferation and apoptosis of CRC cells were detected. As a result, it was identified that miR‑429 expression was downregulated and HMGB3 expression was upregulated in CRC tissues compared with in adjacent non‑cancer tissues, and the expression levels of miR‑429 were negatively associated with those of HMGB3. Notably, HMGB3 was demonstrated to be a direct target of miR‑429 by dual‑luciferase reporter assay. Furthermore, transfection with a miR‑429 mimic significantly inhibited HMGB3 expression and led to decreased proliferation and increased apoptosis of CRC cells. On the other hand, transient overexpression of HMGB3 partially inhibited the antitumor effects of miR‑429. To the best of our knowledge, the present study demonstrated for the first time that miR‑429 regulated the proliferation and apoptosis of CRC cells via HMGB3, suggesting a specific tumor suppressive function of the miR‑429/HMGB3 signaling pathway in CRC.Keywords
This publication has 23 references indexed in Scilit:
- MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signalingOncology Reports, 2015
- Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patientsTumor Biology, 2015
- miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinomaMolecular and Cellular Biochemistry, 2014
- Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 RegulationPLOS ONE, 2013
- Prognostic value of HMGB3 expression in patients with non-small cell lung cancerTumor Biology, 2013
- HMGB3 characterization in gastric cancerGenetics and Molecular Research, 2013
- Multiple promoters and targeted microRNAs direct the expressions of HMGB3 gene transcripts in dairy cattleAnimal Genetics, 2012
- The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyBritish Journal of Cancer, 2011
- NUP98–HMGB3: a novel oncogenic fusionLeukemia, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001